Is Decentralized Manufacturing The Future Of Cell Therapy Manufacturing?
Source: Life Science Leader
In this executive virtual roundtable (EVR) component, Bryan Butman, Ph.D., head of CMC, Precigen, a discovery and clinical stage biopharmaceutical company advancing gene and cell therapies using precision targeting technology, discusses the centralized approach to cell therapy manufacturing, along with his company’s approach of reducing dependence on the cold chain by implementing a decentralized manufacturing approach.
This website uses cookies to ensure you get the best experience on our website. Learn more